Skip to main content
. 2022 May 9;2(5):330–341. doi: 10.1158/2767-9764.CRC-22-0083

TABLE 1.

BCMA expression by IHC on different B-cell malignancies. Per tumor type, the amount of tumor cells was determined. BCMA positivity either on membrane or in golgi was determined as percentage of total tumor cells. Percentages were assessed independently by two pathologists.

Disease N %Tumor cells %BCMA+ of tumor cells BCMA membrane intensity BCMA golgi intensity
MM 4 70–98 60–90 Absent to strong Weak to strong
LPL (WM) 3 20–65 10–90 Weak to moderate Weak to moderate
DLBCL 3 7–90 0–8 Absent to moderate Absent to moderate
CLL 4 90–95 0–0.5 Absent to weak Absent to weak
MCL 3 80–90 0 Absent Absent